Enhanced potency of truncated insulin-like growth factor-I (des(1–3)IGF-I) relative to IGF-I in lit/lit mice

in Journal of Endocrinology


The relative potencies of insulin-like growth factor (IGF-I) and the N-terminal truncated derivative, des(1–3)IGF-I, have been compared in lit/lit mice. Injection of 30 μg IGF-I, 30 μg des(1–3)IGF-I or 3 μg des(1–3)IGF-I daily for 3 weeks increased total length and nose-rump length of the animals substantially more than in controls or animals treated with 3 μg IGF-I daily.

Body weight changes were not statistically significant. The lower dose of des(1–3)IGF-I, but not that of IGF-I, led to increases in kidney and heart weights relative to controls, while the higher dose of either IGF-I or des(1–3)IGF-I also increased the weights of liver, lungs and stomach. These results indicate that the higher potency of des(1–3)IGF-I demonstrated in cultured cells also applies in vivo to at least one strain of GH-deficient animals.

Journal of Endocrinology (1990) 127, 401–405


An official journal of

Society for Endocrinology


Index Card


Google Scholar

Related Articles



All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 51 51 15
PDF Downloads 72 72 34